Incidence of perinatal HIV exposures, in a second level hospital, 3 years experience.

Main Article Content

Edwin Loza Sánchez
Beatriz Venegas Mera

Abstract

Introduction: The incidence of perinatally exposed to HIV has remained in a progressive increase without rampant worldwide and nationally, which has meant a real public health problem and a concern, since these children may or may not develop this disease. For this reason, it is important to take into account a timely diagnosis during pregnancy and in the neonatal period, with responsible management. General objective: To identify the incidence of perinatally exposed children to HIV, managed and diagnosed in a second level hospital, determining which of them developed the disease, an experience of 3 years from 2018 to 2020. Materials and methods Population: Information was obtained from the medical records of the Department of Comprehensive Care and Epidemiology attached to the Statistics Service of the Ambato General Teaching Hospital, which is a second-level health unit, due to the delicacy of said information, from the newborns, who were diagnosed and managed as perinatally exposed to HIV, because their mother is B24 positive. It was an prospective observational cross-sectional study. Results: It is a 3-year study between the period from 2018 to 2020, which corresponded to 12 perinatal HIV-exposed neonates, cesarean section products of HIV-positive mothers who attended prenatal check-ups, of which 7 were male (0.21%) and 5 women (0.15%), and only 2 children (0.16%) developed the disease. Conclusions: It was concluded that the incidence of prenatal exposure during this 3-year period was 0.12%, with a prevalence of 0.20%, with a true risk of infection development of 0.16%, which coincides with the reference data. national. The most affected gender was male.

Downloads

Download data is not yet available.

Article Details

How to Cite
Loza Sánchez, E., & Venegas Mera, B. (2022). Incidence of perinatal HIV exposures, in a second level hospital, 3 years experience. Mediciencias UTA, 6(4), 95–102. https://doi.org/10.31243/mdc.uta.v6i4.1814.2022
Section
Original research article

References

T. K. Consequences of Missed Opportunities for HIV Testing during Pregnancy and Delayed Diagnosis for Mexican Women, Children and Male Partners.. Plos One. 2014 november; 1(1).

MM N, Brown M M, Sandbulte. Using a Social Support Framework to Understand How HIV Positive Kenyan Men Engage in PMTCT/EID Care: Qualitative Insights From Male Partners. Aids and Behavior. 2020 june; 24(1).

HIV. PoATaMMoCLw. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. [Online].; 2021 [cited 2022 September 30. Available from: https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/maternal-hiv-testing-and-identification-perinatal-hiv-exposure.

J. AE, Anderson J, Badell M, Best, PharmD BM, Campbell , Chakraborty Rea. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. [Online].; 2021 [cited 2022 septiembre 30. Available from: https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines.

Li KW, Zhang J, Manepalli KV, Griffith CJ, Castel AD, Scott RK,ea. Prevention of Perinatal HIV Transmission in an Area of High HIV Prevalence in the United States. The Journal of Pediatrics. 2021 January; 228(1).

Roux SMl, Abrams EJ, Donald KA, Brittain , Phillips TKea. , Abrams E, Donald Kea. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study. Lancet. 2019 april; 3(4).

L MD, Allen UD. HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures. Pediatrics Child Health. 2019 February; 24(1).

Lukas C, Murthy P, Staud. HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity. BBA - Molecular Basis of Disease. 2021 june; 1827(2021).

N. CV, Konje JC. HIV in pregnancy – An update. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 january; 278(1).

Paul T, Choong E, Cavassini , Buclin , Decosterd LA. Long-acting antiretrovirals: a new era for the management and prevention of HIV infection. Journal of Antimicrobial Chemotherapy. 2022 february; 77(2).

SCY J, Mora LO, Sanabria NJ. Experiencia en la eliminación de la transmisión vertical del VIH en Evinayong. Rev Ciencias Médicas. 2017 may-jun; 23(1).

Roux KL, Christodoulou , Stansert-Katzen , Dippenaar , Laurenzi , le Roux IMea. Karl R, Christodoulou J, Stansert Lea. A longitudinal cohort study of rural adolescent vs adult South African mothers and their children from birth to 24 months. BMC Pregnancy and Childbrirth. 2019 Enero. BMC Pregnancy and Childbirth. 2019 january; 19(1).

Agustín Z. The new strains and variants. Revista ADM. 2022 Febrero; 79(1).

Omayma A, Powers , Bricker KM, Chahroudi. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for cure. Frontiers in Immunology. 2021 October; 12(1).

Liming W, Zhao , Weiping C, Tao J, Zhao Qea. Liming W, Zhao H, Cai Wa. Risk factors associated with preterm delivery weight among HIV-exposed neonates in China. Int J Gynaecol Obstet. 2018 september; 142(3).

J GC, Patel , B Van Dyke. Is There a Higher Risk of Mother-to-child Transmission of HIV Among Pregnant Women With Perinatal HIV Infection? Pediatr Infect Dis J. 2018 december; 37(12).

Inês CdOM, Silveira da Silva , Marcondes Gomes D. Factors associated with submission to HIV rapid test in childbirth care. Ciência & Saúde Coletiva. 2018 february; 23(2).

Javier PRF. Embarazo y VIH¿ indicación absoluta de cesárea? Ginecología y obstetricia de México. 2018 jun; 86(6).

Placidie M, Lyambabaje , Umubyeyi , Humuza , Tsague L, Mwanyumba Fea. Placidie M, Lyambabaje A, Umubyeyi Aea. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda. BMC Public Health. 2018 november; 1248(2018).

M. IN, Matjila M, Gray CM, Anumba D, Pillay K. Placental pathology in women with HIV. Placenta. 2021 november; 115(1).

Homsy J, King R, Bannink F, Namukwaya Z, Vittinghof Eea. Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial. Plos one. 2018 September. Ploss one. 2019 february; 14(2).

Bryan M, Musonda P, Mee P, Todd J, Michelo C. Educational Attainment as a Predictor of HIV Testing Uptake Among Women of Child-Bearing Analysis of 2014 Demographic and Health Survey in Zambia. Frontiers in Public Health. 2018 august; 14(6).

Abrams E, Anderson, J, Badell, Mea. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. 2022 March; 1(1).

R. NS, Wiener , Weidle PJ. Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978–2013. J Acquir Immune Defic Syndr. 2017 December; 76(5).

Elba W, Galaz , Larrañaga C, Chávez A, González M, Alvarez AM,ea. Infección por VIH/SIDA en niños y adolescentes. Rev Chilena Infectol. 2016; 33(1).

Elba WH. Infección por Virus de Inmunodeficiencia Humana en Niños y Adolescentes, 30 Años en Chile. Rev. chil. pediatr. 2018; 89(5).

Sarah R, Beigi R. Management of viral complications of pregnancy. Obstet Gynecol Clin N Am. 2021; 48.

OMS. https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids. [Online].; 2021 [cited 2021 julio 10. Available from: https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids.

ONUSIDA. https://www.unaids.org/es/resources/fact-sheet. [Online].; 2021 [cited 2022 JULIO 06. Available from: https://www.unaids.org/es/resources/fact-sheet.

OMS. https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids. [Online].; 2022 [cited 2022 septiembre 10. Available from: https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids.

N. CV, Konje JC. HIV in pregnancy – An update. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2021 january; 216(1).

(OARAC) WGotOoARAC. 2020Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Perinatal Guideline 2021 Transmission, The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal. 2021 december; 1(1).

ONUSIDA. Estadísticas mundiales sobre el VIH. HOJA INFORMATIVA 2021. estados Unidos: ONUSIDA, ONUSIDA; 2022.

Rodrigo T. Boletína anual de VIH/sida Ecuador 2020. Boletín. Quito: Ministerio de Salud Pública, Dirección Nacional de Estrategias de Prevención y Control.; 2020.

ONUSIDA. Monitoreo global SIDA 2022: Indicadores y preguntas para el seguimiento de los progresos de la Declaración Política sobre el VIH y el SIDA de 2021. Monitoreo global. Washington: ONUSIDA, ONUSIDA; 2022.

Felix G. Infección por el VIH/sida: ¿ El principio del fin de la primera gran pandemia contemporánea?. Revista Clínica Española. 2017 february; 217(8).

ONISIDA. Hoja informativa — Últimas estadísticas sobre el estado de la epidemia de sida. Hoja informativa. Ginebra: ONUSIDA, ONUSIDA; 2021.

clinicainfo.hiv.gov. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. [Online].; 2021 [cited 2021 December 01. Available from: https://clinicalinfo.hiv.gov/es/node/9210

Similar Articles

<< < 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.